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Hemostasis for Massive Hemorrhage 
during Cesarean Section
Jun Takeda, Shintaro Makino and Satoru Takeda
Abstract
Arterial ligation for massive hemorrhage during cesarean section may often fail 
to achieve hemostasis because of abundant collateral circulation. In recent years, 
various methods of hemostasis have been used, of which the most common are 
compression sutures, uterine balloon tamponade. In cases of massive hemorrhage, 
patients must be kept in good systemic condition, and local hemostasis must be 
achieved while paying attention to the possible occurrence of coagulopathy under 
monitoring of fibrinogen levels. When concomitant coagulopathy is present, local 
hemostasis is difficult to achieve because of hemorrhagic tendency. In such a case, 
obstetrical damage control procedures should be performed. First, the hemorrhagic 
area should be compressed with a towel or balloon, and at the same time, the artery 
should be blocked or compressed to reduce the blood flow into the uterus. The 
following resuscitation must also be implemented for warming intervention; blood 
transfusion to maintain the circulating blood volume; and the treatment of coagu-
lopathy by “triple C supplement,” such as combined administration of fresh-frozen 
plasma and concentrated coagulation factors promptly to obtain a blood fibrinogen 
level of at least 150–200 mg/dL. If coagulopathy is eliminated, the conventional 
hemostatic procedures become effective. Hysterectomy is the last measure for 
hemostasis.
Keywords: cesarean section, compression suture, interventional radiology,  
massive hemorrhage, obstetrical damage control, uterine balloon tamponade
1. Introduction
The maternal mortality rate in Japan had been decreasing steadily until 2007 
(3.1 per 100,000 total births), but thereafter, it showed a fluctuating pattern. The 
rate was 2.7 per 100,000 total births in 2014 but increased to 3.4 per 100,000 total 
births in 2016. The major causes of maternal deaths include, in descending order of 
frequency, critical obstetrical hemorrhage, intracranial hemorrhage, amniotic fluid 
embolism, aortic vessel disease, respiratory disease, and infectious diseases [1]. 
Japan has approximately 1 million deliveries per year. A survey conducted by a study 
group of the Ministry of Health, Labour and Welfare estimated that 4000–5000 
cases of pregnancy-related critical illness, if not death, occur every year [2]. Among 
these cases of critical illness, massive hemorrhage is the most frequent cause and is 
treated by various hemostatic procedures, hysterectomy, or transcatheter arterial 
embolization (TAE). An analysis of the patients who survived showed that mas-
sive hemorrhage during cesarean section accounted for approximately 70% of all 
cases [2]. Most cases had placenta previa accreta, bleeding from the surface of the 
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placental separation, or concomitant coagulopathy with hemorrhagic tendency 
[2, 3]. Therefore, the technique of controlling hemorrhage during cesarean sec-
tion must be mastered. On the other hand, the widespread use of TAE has made it 
possible to save the patient’s life in most cases of massive hemorrhage after vaginal 
delivery, unless uterine rupture or some other serious conditions occur [3, 4].
Obstetrical hemorrhage occurs abruptly and in a large quantity. If the amount of 
bleeding exceeds 2000 ml, disseminated intravascular coagulation (DIC) is likely 
to occur concomitantly. When coagulopathy is present, adequate uterine contrac-
tion may not occur, resulting in atonic hemorrhage, which causes further hemor-
rhage that leads to a vicious circle of adverse events. In view of this particularity of 
obstetrical hemorrhage, the Japanese Clinical Practice Guide for Critical Obstetrical 
Hemorrhage was developed in 2010. The current revised edition of this guideline 
[5] recommends a new concept of obstetrical transfusion therapy, treatment of 
coagulopathy, and hemostatic techniques such as compression sutures, intrauterine 
balloon tamponade, administration of uterotonics and tranexamic acid [3, 5–9]. If 
coagulopathy is present, the fibrinogen level becomes extremely low, and reversal 
of hemorrhagic tendency can be achieved only by administration of cryoprecipitate 
or fibrinogen concentrate or transfusion of fresh-frozen plasma (FFP) [3, 5, 10]. 
In addition, simulation training for obstetrical emergency care has been conducted 
widely to promote good team medical care in emergency settings [1].
This chapter provides an outline of hemostatic procedures that should be per-
formed for massive hemorrhage during cesarean section, without hastily adopting 
hysterectomy. In addition, the methods of transfusion to achieve early hemostasis 
in order to meet the pathological condition of coagulopathy with hemorrhagic 
tendency and the procedures for obstetrical damage control in cases with DIC will 
also be described.
2. Hemostatic strategy for massive hemorrhage during cesarean section
2.1 Systemic management and treatment of hypofibrinogenemia
Once hemorrhage has occurred, it is important not only to determine red blood 
cell (RBC) count, hemoglobin level, hematocrit value, and biochemical parameters 
but also to measure plasma fibrinogen levels over time by using a simple rapid 
fibrinogen measuring instrument as point-of-care testing in order to perform 
early diagnosis and treatment of coagulopathy [5, 10]. In cases of massive hemor-
rhage, it may be difficult to assess the accurate amount of bleeding. In many cases, 
the amount of bleeding is underestimated, and the timing of transfusion may be 
delayed. Therefore, maintaining the blood pressure such as infusion of large volumes 
of artificial colloid solution and albumin solution, and quick implementation of 
temporizing hemostatic procedures such as packing, manual uterine compression, 
and aortic compression, are important until the access to blood transfusion [3].
If circulatory failure persists despite these procedures or if coagulopathy occurs, 
transfusion of RBC concentrate alone cannot maintain the sufficient circulation blood 
volume, on the contrary, it may lead to dilution coagulopathy. Administration of 
FFP is necessary for achieving the elevation and maintenance of blood pressure and 
colloid osmotic pressure. It should be noted that if the patient experiences shock, RBC 
transfusion alone cannot increase blood pressure; FFP and RBC should be adminis-
tered at a ratio of 1:1 in the same manner as in cases of trauma [3, 5, 10]. In cases of 
consumption coagulopathy, such as in placenta abruption or amniotic fluid embo-
lism, and coagulopathy following massive hemorrhage, the blood fibrinogen level 
is often <100 mg/dL. Therefore, elimination of the hemorrhagic tendency requires 
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transfusion of 10–15 units of FFP; usually 15 units of FFP are necessary to increase the 
blood fibrinogen level by 100 mg/dL. To eliminate the hemorrhagic tendency, rapid 
transfusion of at least 10 units of FFP, rather than RBC, must be performed. Without 
this treatment, hemorrhage may persist, and the hemorrhagic tendency may continue 
for days [11]. The mainstay coagulopathy management is elimination of coagulopathy 
within 6 h. For this purpose, rapid transfusion of FFP should be performed to obtain 
a blood fibrinogen level of ≥150–200 mg/dL, and a prothrombin time of ≥70% 
should be targeted [3, 5, 10, 11]. After these treatments, the FFP/RBC ratio of the total 
transfusion volume may exceed 2.0 in some cases. If blood of the same type is lacking 
or there is no time for cross-matching in cases of life-threatening critical hemorrhage, 
not crossmatched compatible RBC such as type O RBC and type AB FFP should be 
used without hesitation [5]. Rapid transfusion of FFP may cause asymptomatic (satu-
ration of percutaneous oxygen [SpO2] of ≤95%) or symptomatic pulmonary edema 
[5]. Therefore, early treatment with a diuretic, carperitide, or a β-agonist should be 
provided while monitoring the central venous pressure or SpO2, or more concentrated 
blood product, such as fibrinogen concentrate and cryoprecipitate, should be given.
In patients with hypofibrinogenemia, the blood fibrinogen level could be more 
promptly, more efficiently elevated by administration of 3 g of fibrinogen concen-
trates (3 g of fibrinogen concentrate is almost equivalent to fibrinogen in 12 units 
of FFP) or three bags of cryoprecipitate (one bag of cryoprecipitate is derived from 
approximately 480 ml of FFP) [10–13]. If the patient develops coagulopathy, any 
other coagulation factors than fibrinogen will also decrease. Therefore, FFP and 
cryoprecipitate are necessary to maintain the sufficient circulation blood volume 
and supplement other coagulation factors. As the supplies of fibrinogen concen-
trate and cryoprecipitate have limitations according to the country and region, 
“Combined administration of FFP and concentrated coagulation factors (triple C) 
supplement” has been recommended for treating coagulopathy through efficient 
administration of these three agents to supplement sufficient coagulation factors, 
especially fibrinogen, to replace blood volume and to maintain blood pressure and 
colloid osmotic pressure. Management of massive hemorrhage with a focus on 
“triple C supplement” never caused hemostatic failure that required hysterectomy 
in >300 patients with cesarean section in whom placenta abruption was accompa-
nied by coagulopathy.
2.2 Local hemostasis
2.2.1 Hemostasis for the surface of the placental separation
For severe hemorrhage from the surface of the placental separation in cases 
of placenta previa or placenta accreta, pressure hemostasis with gauze and suture 
hemostasis have been performed commonly, but these procedures are often unsuc-
cessful in the presence of bleeding from a large area. Although separation of the 
bladder may be necessary on the anterior wall, the use of a simple suture or Z-suture, 
piercing the whole myometrium at several sites [3]; a large U-shaped suture; an 
interrupted circular suture consisting of repeated simple sutures in the entire 
circumference of the anterior and posterior walls [14]; and a suture of the muscular 
layer to block blood flow in four directions has been reported [3, 14, 15]. On the 
other hand, Bakri [16] reported that uterine balloon tamponade was effective for 
controlling hemorrhage from the surface of separation of the placenta previa. This 
method is also effective for hemostasis during cesarean section (Figure 1) [6].
On the other hand, the success rate of internal iliac artery ligation and uterine 
artery ligation for uterine bleeding is limited and unsatisfactory, because of marked 
blood inflows via abundant anastomosis of the peripheral uterine artery from the 
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external iliac artery and the aorta [3]. Uterine devascularization, by which the distal 
portion of uterine artery and the ovarian artery are ligated on the uterine side, has 
a strong hemostatic effect [17]. However, functional disorders of the uterus and 
ovaries were reported, such as ovarian dysfunction, oligomenorrhea, endometrial 
hypoplasia, infertility, uterine cavity adhesions and uterine necrosis [3, 18].
2.2.2 Compression sutures
In cases of atonic hemorrhage, the technique of compression sutures (B-Lynch 
technique), which was first reported by B-Lynch et al. [19], is used when bimanual 
compression and administration of uterotonics fail to control bleeding. This 
technique uses compression of the bleeding surface by joining the anterior and 
posterior walls of the uterus together. The B-Lynch technique is effective for both 
hemorrhage from the surface of separation of the placenta previa and atonic hemor-
rhage and is used for controlling hemorrhage in the lower segment (isthmus) and 
body of the uterus. As the B-Lynch technique consists of complicated procedures, 
various modifications have been devised and reported [3, 20]. Various hemostatic 
techniques include those involving the uterine body or the lower uterine segment 
(isthmus) alone, or both parts of the uterus for atonic hemorrhage [21, 22].
In our technique of uterine isthmus vertical compression sutures, we used two 
vertical sutures to achieve pressure hemostasis by sewing the anterior and poste-
rior walls at the uterine isthmus together vertically. This technique is effective for 
controlling not only hemorrhage in the placenta previa but also atonic hemorrhage 
Figure 1. 
Balloon insertion during cesarean section. (Produced with permission from Makino et al. [6].) (A) Balloon 
was inserted through the uterine wound. (B) Eighty to two hundred milliliter of saline is sufficient to achieve 
hemostasis.
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(Figure 2) [3, 6, 21–23]. After exposing the muscular layer in the lower uterus, two 
stitches piercing the anterior and posterior walls, one each on the right and left sides, 
were made to place ligation sutures vertically. When the initial vertical compression 
sutures fail to achieve hemostasis or when there is concomitant coagulopathy, the 
technique of double vertical compression sutures, a combination of compression 
sutures and a modified B-Lynch technique, should be used (Figure 2) [6, 21]. 
Synthetic absorbable threads such as Vicryl Rapide® are used. Only two stitches of 
vertical sutures can also cause pain because of uterine ischemia in some patients, and 
laparoscopic removal of the thread is required occasionally [24]. This suggests that 
the procedure of vertical compression sutures not only causes hemostasis by pressing 
the bleeding surface but also blocks the blood flow entering the uterus from the right 
and left sides through thread suturing the uterus vertically [22, 25–27]. Therefore, 
further investigation is necessary as to whether thread removal should be performed 
even when a quickly absorbable thread is used.
2.2.3 Interventional radiology
Techniques of interventional radiology (IVR) for massive hemorrhage during 
cesarean section include the arterial balloon occlusion technique by which an arte-
rial balloon catheter is inserted preoperatively to prevent massive hemorrhage and 
the TAE technique, which is performed intraoperatively in the hybrid operating 
room [3, 28–30]. The former technique is used in cases of placenta previa accreta 
and in myomectomy after fetal delivery in cases of pregnancy with a giant myoma. 
When massive hemorrhage is predicted preoperatively or when hysterectomy is to 
be performed for placenta accreta, an arterial balloon is placed in the aorta, common 
iliac artery, and so on. In cases where a procedure that may induce hemorrhage is 
used or where hemorrhage occurs, the balloon will be inflated to block the arterial 
Figure 2. 
Double vertical compression sutures. (Produced with permission from Makino et al. [6].) Compression sutures 
at the uterine isthmus are placed to achieve hemostasis for the atonic bleeding or hemorrhage from a placenta 
previa. Additional sutures could be placed, as with the modified B-Lynch suture technique, if (A) is not 
effective.
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blood flow temporarily to reduce hemorrhage (Figure 3) [29–32]. The TAE technique 
is used for embolization of the bleeding artery in patients operated on in a hybrid 
operating room equipped with the fluoroscopic apparatus or in surgical patients who 
are temporarily transferred to a room where a fluoroscopic apparatus is available. 
This technique is considered useful for patients in whom various local hemostatic 
procedures have failed to control hemorrhage [28, 29]. However, the association of 
TAE with prolonged uterine ischemia has become apparent, even when an absorbable 
embolus such as Spongel® is used [33, 34]. The following complications of TAE have 
been reported: Asherman syndrome; infertility; ovarian dysfunction (increase in 
follicle-stimulating hormone levels); endometrial hypoplasia; menstruation disorders 
(e.g., amenorrhea, menstrual irregularity, oligomenorrhea, and hypomenorrhea); 
and pregnancy wastage, puerperal massive hemorrhage, placenta accreta, placenta 
previa, and uterine rupture in subsequent pregnancies [3, 4, 28, 29, 33, 34]. Therefore, 
TAE and hysterectomy should be recognized as a last measure to be used only when 
the a forementioned techniques have failed to achieve hemostasis (Figure 2) [3].
3. Obstetrical damage control
Hemostasis often cannot be achieved promptly in cases of massive hemorrhage 
accompanied by coagulopathy. In such cases, damage control surgery (DCS) and 
Figure 3. 
Hemostatic strategy during cesarean section. (Produced with permission from Takeda et al. [3].) Balloon 
tamponade or several sutures have priority over TAE or arterial ligation. TAE: transcatheter arterial embolization.
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resuscitation, which represent the therapeutic concept of life-saving intervention 
for severe trauma accompanied by massive hemorrhage, should be performed  
[35, 36]. In the field of emergency medical care, DCS rather than standard surgery 
is performed in patients having hemorrhagic shock. The primary cause of intraop-
erative and postoperative deaths in patients with severe trauma accompanied by 
massive hemorrhage is not loss of blood from the uncontrollable bleeding source 
but a combination of three abnormalities, namely metabolic acidosis, hypothermia, 
and blood clotting disorder. These abnormalities are called the lethal triad of death 
from trauma, resulting from collapse of physiological homeostasis [35, 36]. To treat 
this condition, gauze or towel packing of the abdomen or the whole pelvis should 
be performed to provide pressure hemostasis as a part of the DCS [37, 38]. In the 
meantime, the patient’s vital signs and body temperature must be monitored and 
assessed over time. The patient should be managed to keep in appropriate body 
temperature. Blood transfusion should be performed to resuscitate the patient from 
shock and coagulopathy. If hemostasis is judged to be unachievable, the patient 
should be transported to a higher-level medical facility after performing temporary 
abdominal closure with intra-abdominal packing [3]. Charoenkwan reported the 
use of Barki balloon, a method similar to towel packing, to control hemorrhage 
from the pelvic floor after hysterectomy and from the posterior aspect of the uterus 
after cesarean section [39, 40].
Hemorrhage may become uncontrollable owing to coagulopathy during cesarean 
section for cases such as placenta abruption. In these cases, the first measure to 
be taken is not immediate initiation of hysterectomy. Instead, both application of 
pressure with a towel or a balloon, and treatment of coagulopathy, in an attempt 
to prevent the lethal triad of death, may allow avoidance of hysterectomy [11]. 
Treatment of coagulopathy is accomplished with “triple C supplement” that is a com-
bined administration of FFP and concentrated coagulation factors, such as fibrinogen 
concentrate, cryoprecipitate, antithrombin, and so on. As the patient’s condition may 
worsen during hysterectomy, pressure should be applied with gauze or a towel after 
removal of the uterus, and the focus should be on volume replacement, warming 
of the patient, and treatment of coagulopathy. When the hemorrhagic tendency is 
improved, drain insertion and abdominal closure are performed. Thus, implementa-
tion of resuscitation while the surgical procedure is suspended allows avoidance of 
unnecessary hysterectomy and hemorrhagic death [3, 11].
In any event, it is important to be familiar with the practice guidelines and emer-
gency care measures for obstetrical critical hemorrhage and to run a simulation 
of the preparation and actions to be taken in emergency settings. Such simulation 
training should involve the whole hospital, including not only the obstetrical team 
consisting of medical and paramedical staff members but also the clerical personnel 
in charge of the arrangement of blood transfusion, human resources, transfer of 
patients, and so on. This study emphasizes the importance for obstetrical staff to 
actively participate in educational programs about maternal emergency in order to 
prepare for any emergency [1].
4. Conclusion
In cases of massive hemorrhage during cesarean section and in other situations, 
performing local hemostatic measures while keeping the patient in good systemic 
condition, monitoring the fibrinogen level, and paying attention to possible occur-
rence of coagulopathy are important. Minimally invasive hemostasis that has little 
influence on subsequent pregnancies and deliveries should be attempted [3]. If 
DIC is present, hemorrhage becomes difficult to control with the usual hemostatic 
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procedures; therefore, “triple C supplement,” such as combined administration of 
concentrated coagulation factors and FFP is necessary in parallel with hemostasis.
If massive hemorrhage occurs during surgery and coagulopathy occurs con-
comitantly, effective hemostasis cannot be achieved because of the hemorrhagic 
tendency. In this case, obstetrical damage control should be performed [3, 11]. First, 
pressure should be applied to the hemorrhagic area with a towel or balloon, and at 
the same time, arterial blockage or compression should be performed to decrease 
the blood flow into the uterus. Second, warming of the patient should be imple-
mented. Third, blood transfusion should be performed to maintain the sufficient 
circulation blood volume. Rapid “triple C supplement” is also important to obtain a 
blood fibrinogen level of at least 150–200 mg/dL for the treatment of coagulopathy. 
If coagulopathy is eliminated, the usual balloon tamponade, compression sutures, 
arterial ligation, and so on become effective. Hysterectomy should be considered as 
a last hemostatic measure.
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